GlassScriptPhysician profile
Heather Ferrillo
NPI 1194723866
$851.50
in general payments reported to CMS, 2019-2025
16 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.89 · 2022: $185 · 2023: $233 · 2024: $260 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.52 | 2024 | Wegovy |
| Abbvie INC. | $117.71 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $106.81 | 2023-2024 | |
| Redhill Biopharma INC. | $78.14 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $72.02 | 2022-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $63.98 | 2021-2025 | Jemperli, Shingrix, Arexvy |
| Amarin Pharma, INC. | $57.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.24 | 2022-2025 | |
| Amgen INC. | $37.37 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $34.55 | 2024-2025 | Eliquis, Camzyos |
| Lundbeck LLC | $26.40 | 2025 | Rexulti |
| Alnylam Pharmaceuticals INC. | $26.23 | 2025 | Onpattro |
| Ardelyx, INC. | $20.39 | 2024 | Ibsrela |
| Kiniksa Pharmaceuticals, LTD. | $17.17 | 2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $15.43 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $10.94 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Ferrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.